Market Overview:
The global hypnotics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of insomnia and other sleep disorders, rising demand for sedatives and anxiolytics, and growing awareness about the benefits of hypnotics drugs. The global hypnotics market is segmented on the basis of type into suppository, capsule, solution, injectable, and others. On the basis of application, it is segmented into hospital use, clinic use, and others. Geographically it is segmented into North America (U.S., Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) Middle East & Africa(South Africa).
Product Definition:
Hypnotics are medications or drugs that cause a person to enter into a hypnotic state. This type of medication is used to help people manage pain, anxiety, and sleep problems.
Suppository:
Suppository is a drug that is administered by means of the rectum. It's primary function is to remove waste products from the body, and it does this by way of bowel movements every day. Suppositories can also be used for other purposes such as pain management or to prevent diarrhea. The main ingredient in all suppository drugs consists of one or more active ingredients that are absorbed into the skin and then carried into the blood vessels where they perform their task; i.e.
Capsule:
Capsule is a small package containing drug substance and drug carrier (bulk-fill) which is used in various hypnosis medications. Hypnotics are drugs that induce sleep; they are also known as sedatives. They work by enhancing the effect of histamine (the body's natural anti-histamine) by blocking its receptors in the brain, thereby resulting in drowsiness or sleep.
Application Insights:
Based on application, the global hypnotics market is segmented into hospital, clinic and others. The hospital held the largest share of over 70.0% in 2017 owing to increasing prevalence of sleep disorders such as insomnia and hypersomnia among both children and adults across the globe. Growing number of hospitals due to increase in population coupled with rising spending power are factors contributing towards high share held by this segment. Moreover, an increase in travel activities has led to an increased demand for hypnosis during medical emergencies at a time when most people are asleep or unconsciousness due to trauma or pain which further propels its usage at hospitals only thus boosting overall market growth during this period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to high demand for sleep disorder treatment, increasing cases of obesity, and rising prevalence of stress-related disorders. Moreover, presence of key players in this region will also help maintain dominance.
Asia Pacific is anticipated to be the fastest-growing regional market from 2018 to 2030 owing to growing awareness about hypnotics among patients and physicians as well as an increase in spending capacity due to rise in disposable income resulting from economic growth. In addition, favorable regulatory policies are also expected favorably impact revenue generation over the forecast period in this region as well as other regions where major companies have their operational base (Europe & North America).
Latin America has a wide scope for growth on account of increasing number of prescriptions being written every year by doctors for sleeping pills and anti-anxiety medication such as alprazolam (Xanax).
Growth Factors:
- Increasing prevalence of sleep disorders: The increasing prevalence of sleep disorders is one of the key growth drivers for the hypnotics market. According to a study by the National Sleep Foundation, around 50-70 million adults in the U.S. suffer from chronic sleep problems. This number is expected to increase in the coming years due to changing lifestyles and growing stress levels. This will create a high demand for hypnotics drugs, which will drive market growth during the forecast period
- Rising geriatric population: The geriatric population is at an increased risk of developing various sleep disorders such as insomnia, restless leg syndrome (RLS), and obstructive sleep apnea (OSA). According to estimates by Population Reference Bureau (PRB), there were around 44 million people aged 65 or above in 2010 in U.S., and this number is projected to reach 83 million by 2050. This will create a high demand for hypnotics drugs among geriatric population, driving market growth during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Hypnotics Market Research Report
By Type
Suppository, Capsule, Solution, Injectable,
By Application
Hospital, Clinic,
By Companies
Abbott, Cobalt Laboratories, Sands Pharm, Sanofi, Hospira, Takeda, Fresenius Kabi, Pfizer, Mylan, Novartis, Baxter
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Hypnotics Market Report Segments:
The global Hypnotics market is segmented on the basis of:
Types
Suppository, Capsule, Solution, Injectable,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Cobalt Laboratories
- Sands Pharm
- Sanofi
- Hospira
- Takeda
- Fresenius Kabi
- Pfizer
- Mylan
- Novartis
- Baxter
Highlights of The Hypnotics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Suppository
- Capsule
- Solution
- Injectable
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hypnotics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hypnotics are medications that can induce a state of relaxation or sleep.
Some of the major companies in the hypnotics market are Abbott, Cobalt Laboratories, Sands Pharm, Sanofi, Hospira, Takeda, Fresenius Kabi, Pfizer, Mylan, Novartis, Baxter.
The hypnotics market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hypnotics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hypnotics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hypnotics Market - Supply Chain
4.5. Global Hypnotics Market Forecast
4.5.1. Hypnotics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hypnotics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hypnotics Market Absolute $ Opportunity
5. Global Hypnotics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hypnotics Market Size and Volume Forecast by Type
5.3.1. Suppository
5.3.2. Capsule
5.3.3. Solution
5.3.4. Injectable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hypnotics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hypnotics Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hypnotics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hypnotics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hypnotics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hypnotics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hypnotics Demand Share Forecast, 2019-2026
9. North America Hypnotics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hypnotics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hypnotics Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hypnotics Market Size and Volume Forecast by Type
9.7.1. Suppository
9.7.2. Capsule
9.7.3. Solution
9.7.4. Injectable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hypnotics Demand Share Forecast, 2019-2026
10. Latin America Hypnotics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hypnotics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hypnotics Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hypnotics Market Size and Volume Forecast by Type
10.7.1. Suppository
10.7.2. Capsule
10.7.3. Solution
10.7.4. Injectable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hypnotics Demand Share Forecast, 2019-2026
11. Europe Hypnotics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hypnotics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hypnotics Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hypnotics Market Size and Volume Forecast by Type
11.7.1. Suppository
11.7.2. Capsule
11.7.3. Solution
11.7.4. Injectable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hypnotics Demand Share, 2019-2026
12. Asia Pacific Hypnotics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hypnotics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hypnotics Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hypnotics Market Size and Volume Forecast by Type
12.7.1. Suppository
12.7.2. Capsule
12.7.3. Solution
12.7.4. Injectable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hypnotics Demand Share, 2019-2026
13. Middle East & Africa Hypnotics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hypnotics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hypnotics Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hypnotics Market Size and Volume Forecast by Type
13.7.1. Suppository
13.7.2. Capsule
13.7.3. Solution
13.7.4. Injectable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hypnotics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hypnotics Market: Market Share Analysis
14.2. Hypnotics Distributors and Customers
14.3. Hypnotics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cobalt Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sands Pharm
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sanofi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Hospira
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Takeda
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Fresenius Kabi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pfizer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mylan
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Novartis
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Baxter
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook